by Crohn’s & Colitis UK and Takeda with support from Aurora Healthcare Communications
by London Joint Working Group on Substance Use and Hepatitis C with support from Principle Consulting and MSD
by AbbVie with support from Biosector 2, a Syneos Health™ Company
by Actelion Pharmaceuticals UK Ltd with support from NexGen Healthcare Communications
by British Society of Gastroenterology (BSG) with support from Dovetail
by Actelion Pharmaceuticals UK Ltd with support from NexGen Healthcare Communications
‘Act on PAH – Improve patient outcomes with early diagnosis’ is a multichannel educational initiative focused on reducing time to diagnosis of patients with suspected pulmonary arterial hypertension (PAH), a rare, rapidly progressive, life-limiting condition.
The initiative was developed in partnership with:
‘Act on PAH’ was developed, with input from PH experts, as a resource for non-PH specialist physicians, nurses and those health professionals involved in echo. The objectives were to increase the awareness and understanding of PAH, and equip target non-PH specialist HCPs with the knowledge and tools to identify and refer patients with suspected PAH earlier, resulting in earlier diagnosis, treatment and improved patient outcomes.
The dynamic programme includes a flagship national launch event, an educational website, regional and local meetings, and is supported by KAM field-based activities and digital promotion. The programme has maximised audience interaction and motivated HCPs to ‘Act on’ their learnings, by implementing immediate changes in referral behaviour and sharing knowledge with colleagues. Patient organisation involvement has helped to bring the impact of this devastating condition to life.
A compelling campaign which demonstrated true patient-centricity and met its objectives. Actelion have produced a strong medical education programme, demonstrating good collaboration.
Entry deadline | 25 August 2023 |
Extended entry deadline | 1 September 2023* *additional fee applies |
Judging Day | 10 October 2023 |
Company/Team of the Year Interviews | 3 November 2023 |
PMEA Event | 22 November 2023 |